Overview
Digital health technologies (DHTs) can address critical limitations in the current drug development process, and a growing body of evidence now supports their usability and value in clinical trials. DHTs can add value in specific areas of clinical study design resulting in an increased chance of detecting a treatment effect as well as decreased trial size and time.
Here, we’ve collected 4 real-world examples of clinical trials that incorporated DHTs. We assess the aspect of clinical trial design that DHTs had an impact on and the value this helped clinical trial sponsors realize in these specific use cases.
Featured Case Studies
- Physical Activity Assessment in Rare Cardiopulmonary Disease Trial
- Physical Activity Assessment in Neurodegenerative Disease Trial
- Physical Activity Assessment in Autoimmune Disease Trial
- Sleep Assessment in Sleep Disorder Trial